13 June, 2017
InterContinental Shanghai Pudong
CellWorld is an invitation-only conference for innovators, visionaries and senior executives in bioprocessing to discuss the future of biosimilar manufacturing and learn about both disruptive technologies and best practices for continuous processing and personalized medicine.
Invited speakers will cover advances in both upstream and downstream single-use bioprocessing with a focus on modular automation and data harmonization and analytics as well as small-volume bioproduction for immunotherapy. CellWorld sessions will include the introduction of new tools for end-to-end continuous processing from labscale through manufacturing, including the Finesse G4 automation platform, and the SmartFactory™ that minimizes the required size of new manufacturing plants while efficiently using available capacity.
We are excited to host our second international forum in Silicon Valley and discuss the challenges and advances in areas such as CAR-T, applications of CRISPR/CAS9 and gene editing to personalized medicine, continuous processing, and mass production of biosimilars in BRIC countries. Our goal is to provide a unique venue for senior leadership in our industry to explore innovation and technology in cutting-edge bioprocessing applications.
~ Dr. Barbara Paldus, CEO of Finesse Solutions